vs
Side-by-side financial comparison of CorMedix Inc. (CRMD) and OneStream, Inc. (OS). Click either name above to swap in a different company.
OneStream, Inc. is the larger business by last-quarter revenue ($163.7M vs $128.6M, roughly 1.3× CorMedix Inc.). CorMedix Inc. produced more free cash flow last quarter ($92.7M vs $25.6M).
CorMedix Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing novel therapeutic products for the prevention and treatment of infectious, inflammatory and cardiorenal diseases. Its lead candidate targets catheter-related bloodstream infections, serving critical care and chronic dialysis patient populations primarily across North America and European markets.
Blue Stream provides cable television, cable telephone, DVR, and up to 1 GIG Internet speed broadband services to customers in the Florida communities of Coral Springs and Weston.
CRMD vs OS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $128.6M | $163.7M |
| Net Profit | — | $999.0K |
| Gross Margin | 83.4% | 69.8% |
| Operating Margin | 46.0% | -3.2% |
| Net Margin | — | 0.6% |
| Revenue YoY | — | 23.6% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.20 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $128.6M | $163.7M | ||
| Q3 25 | $104.3M | $154.3M | ||
| Q2 25 | $39.7M | $147.6M | ||
| Q1 25 | $39.1M | $136.3M | ||
| Q4 24 | — | $132.5M | ||
| Q3 24 | — | $129.1M | ||
| Q2 24 | — | $117.5M | ||
| Q1 24 | — | $110.3M |
| Q4 25 | — | $999.0K | ||
| Q3 25 | $108.6M | $-8.8M | ||
| Q2 25 | $19.8M | $-18.4M | ||
| Q1 25 | $20.6M | $-24.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-171.9M | ||
| Q2 24 | — | $-7.8M | ||
| Q1 24 | — | $-5.0M |
| Q4 25 | 83.4% | 69.8% | ||
| Q3 25 | 89.3% | 68.1% | ||
| Q2 25 | 95.3% | 68.6% | ||
| Q1 25 | 95.9% | 68.0% | ||
| Q4 24 | — | 66.8% | ||
| Q3 24 | — | 50.1% | ||
| Q2 24 | — | 68.5% | ||
| Q1 24 | — | 69.1% |
| Q4 25 | 46.0% | -3.2% | ||
| Q3 25 | 49.2% | -11.3% | ||
| Q2 25 | 49.2% | -21.8% | ||
| Q1 25 | 51.5% | -29.3% | ||
| Q4 24 | — | -35.8% | ||
| Q3 24 | — | -197.6% | ||
| Q2 24 | — | -9.8% | ||
| Q1 24 | — | -4.9% |
| Q4 25 | — | 0.6% | ||
| Q3 25 | 104.1% | -5.7% | ||
| Q2 25 | 49.9% | -12.5% | ||
| Q1 25 | 52.8% | -17.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -133.1% | ||
| Q2 24 | — | -6.7% | ||
| Q1 24 | — | -4.5% |
| Q4 25 | $0.20 | — | ||
| Q3 25 | $1.26 | — | ||
| Q2 25 | $0.28 | — | ||
| Q1 25 | $0.30 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-1.06 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $148.5M | $693.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $405.3M | $504.7M |
| Total Assets | $826.1M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $148.5M | $693.6M | ||
| Q3 25 | $55.7M | $653.9M | ||
| Q2 25 | $190.7M | $652.1M | ||
| Q1 25 | $77.5M | $593.9M | ||
| Q4 24 | — | $544.2M | ||
| Q3 24 | — | $495.5M | ||
| Q2 24 | — | $140.5M | ||
| Q1 24 | — | — |
| Q4 25 | $405.3M | $504.7M | ||
| Q3 25 | $374.1M | $472.1M | ||
| Q2 25 | $220.6M | $458.2M | ||
| Q1 25 | $114.9M | $412.9M | ||
| Q4 24 | — | $386.2M | ||
| Q3 24 | — | $458.2M | ||
| Q2 24 | — | $97.5M | ||
| Q1 24 | — | $102.5M |
| Q4 25 | $826.1M | $1.0B | ||
| Q3 25 | $750.9M | $949.4M | ||
| Q2 25 | $252.6M | $910.5M | ||
| Q1 25 | $149.6M | $867.3M | ||
| Q4 24 | — | $823.2M | ||
| Q3 24 | — | $750.1M | ||
| Q2 24 | — | $379.7M | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $94.5M | $25.8M |
| Free Cash FlowOCF − Capex | $92.7M | $25.6M |
| FCF MarginFCF / Revenue | 72.1% | 15.7% |
| Capex IntensityCapex / Revenue | 1.3% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 25.79× |
| TTM Free Cash FlowTrailing 4 quarters | $172.8M | $95.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $94.5M | $25.8M | ||
| Q3 25 | $30.9M | $5.0M | ||
| Q2 25 | $30.0M | $29.7M | ||
| Q1 25 | $19.7M | $36.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | — | $8.1M | ||
| Q1 24 | — | $25.5M |
| Q4 25 | $92.7M | $25.6M | ||
| Q3 25 | $30.4M | $4.8M | ||
| Q2 25 | $30.0M | $29.4M | ||
| Q1 25 | $19.7M | $35.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | — | $7.7M | ||
| Q1 24 | — | $24.9M |
| Q4 25 | 72.1% | 15.7% | ||
| Q3 25 | 29.1% | 3.1% | ||
| Q2 25 | 75.4% | 19.9% | ||
| Q1 25 | 50.5% | 26.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.0% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 22.5% |
| Q4 25 | 1.3% | 0.1% | ||
| Q3 25 | 0.5% | 0.1% | ||
| Q2 25 | 0.1% | 0.2% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.3% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | 25.79× | ||
| Q3 25 | 0.28× | — | ||
| Q2 25 | 1.51× | — | ||
| Q1 25 | 0.96× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRMD
| Acquisition Of Melinta | $52.9M | 41% |
| Melinta Portfolio | $45.5M | 35% |
| Other | $18.6M | 14% |
| Contract Revenue | $7.4M | 6% |
| BARDA Agreement | $4.2M | 3% |
OS
| Subscription And Circulation | $150.3M | 92% |
| Professional Services And Other | $9.4M | 6% |
| License | $4.0M | 2% |
